Stifel Reiterates Hold Rating on Avanos Medical (AVNS)

Stifel analyst Rick Wise reiterated a Hold rating and $17.00 price target on Avanos Medical (NYSE: AVNS).

The analyst commented, “We believe that AVNS will remain a "show me" story in the near-term as the new leadership clarifies their go-forward strategy, a permanent CFO is brought onboard, and investors get a better sense of nearterm performance. While the stock is inexpensive on current numbers, we leave our Hold rating in place as we await more visible signs of consistent execution, positive fundamental improvement, and further long-term transformational change.”

For an analyst ratings summary and ratings history on Avanos Medical click here. For more ratings news on Avanos Medical click here.

Shares of Avanos Medical closed at $12.43 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Critical One Energy closes second tranche of flow-through placement
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery